CHECKLIST FOR THE SAFEST USE OF DABIGATRAN, RIVAROXABAN & APIXABAN IN ATRIAL FIBRILLATION: INCLUSION & EXCLUSION CRITERIA

被引：0
|
作者：
Leong, Wendy A. [1 ,2 ]
机构：
[1] Burnaby Res Vancouver, Vancouver, BC, Canada
[2] Univ British Columbia Vancouver, Vancouver, BC, Canada
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2014年 / 89卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
180
引用
收藏
页码：E86 / E86
页数：1
相关论文
共 50 条
  • [21] Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation
    Hernandez, Inmaculada
    Zhang, Yuting
    Saba, Samir
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (10): : 1813 - 1819
  • [22] Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
    Rutherford, Ole-Christian W.
    Jonasson, Christian
    Ghanima, Waleed
    Soderdahl, Fabian
    Halvorsen, Sigrun
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (02) : 75 - 85
  • [23] Hemostasis POC tests are affected by dabigatran, rivaroxaban and apixaban treatments in patients with atrial fibrillation
    Paniccia, R.
    Marcucci, R.
    Priora, R.
    Liotta, A. Alessandrello
    Poli, D.
    Lembo, G.
    Ahmed, Y.
    Fanciullacci, C.
    Pazzi, M.
    Abbate, R.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1080 - 1080
  • [24] Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
    Harrington, Amanda R.
    Armstrong, Edward P.
    Nolan, Paul E., Jr.
    Malone, Daniel C.
    STROKE, 2013, 44 (06) : 1676 - +
  • [25] Comparative Effectiveness of Dabigatran, Rivaroxaban, Apixaban, and Warfarin in the Management of Patients With Nonvalvular Atrial Fibrillation
    Pink, J.
    Pirmohamed, M.
    Hughes, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (02) : 269 - 276
  • [26] Apixaban, rivaroxaban, and dabigatran use in patients undergoing catheter ablation for atrial fibrillation using the second-generation cryoballoon
    Tscholl, Verena
    Lsharaf, Abdullah Khaled-A.
    Lin, Tina
    Bellmann, Barbara
    Nagel, Patrick
    Lenz, Klaus
    Landmesser, Ulf
    Roser, Mattias
    Rillig, Andreas
    CLINICAL CARDIOLOGY, 2017, 40 (11) : 1095 - 1099
  • [27] EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN FRAIL PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Coleman, Craig I.
    Turpie, Alexander
    Bunz, Thomas J.
    Sood, Nitesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 290 - 290
  • [28] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
    Martinez, Brandon K.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Coleman, Craig I.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [29] Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
    Andersson, Niklas W.
    Svanstrom, Henrik
    Lund, Marie
    Pasternak, Bjorn
    Melbye, Mads
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 113 - 119
  • [30] Apixaban vs rivaroxaban in patients with atrial fibrillation
    Reactions Weekly, 2020, 1796 (1) : 7 - 7
12345